Savara, Inc. (SVRA)
4.72
-0.27
(-5.41%)
USD |
NASDAQ |
Nov 12, 16:00
4.73
+0.01
(+0.21%)
After-Hours: 05:45
Savara Free Cash Flow (Quarterly) : -42.82M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -42.82M |
| June 30, 2026 | -29.97M |
| March 31, 2026 | -33.10M |
| December 31, 2025 | -25.06M |
| September 30, 2025 | -22.53M |
| June 30, 2025 | -26.28M |
| March 31, 2025 | -27.19M |
| December 31, 2024 | -23.27M |
| September 30, 2024 | -22.67M |
| June 30, 2024 | -22.52M |
| March 31, 2024 | -20.65M |
| December 31, 2023 | -15.63M |
| September 30, 2023 | -13.20M |
| June 30, 2023 | -10.50M |
| March 31, 2023 | -12.03M |
| December 31, 2022 | -8.651M |
| September 30, 2022 | -8.166M |
| June 30, 2022 | -9.321M |
| March 31, 2022 | -8.425M |
| December 31, 2021 | -9.403M |
| September 30, 2021 | -8.938M |
| June 30, 2021 | -12.20M |
| March 31, 2021 | -9.597M |
| December 31, 2020 | -12.30M |
| September 30, 2020 | -6.723M |
| Date | Value |
|---|---|
| June 30, 2020 | -7.772M |
| March 31, 2020 | -16.33M |
| December 31, 2019 | -9.956M |
| September 30, 2019 | -11.42M |
| June 30, 2019 | -12.94M |
| March 31, 2019 | -10.96M |
| December 31, 2018 | -10.55M |
| September 30, 2018 | -8.778M |
| June 30, 2018 | -10.40M |
| March 31, 2018 | -9.69M |
| December 31, 2017 | -9.904M |
| September 30, 2017 | -8.25M |
| June 30, 2017 | -7.672M |
| March 31, 2017 | -2.903M |
| December 31, 2016 | -2.19M |
| September 30, 2016 | -2.868M |
| June 30, 2016 | 8.013M |
| March 31, 2016 | -11.33M |
| December 31, 2015 | -8.858M |
| September 30, 2015 | -8.283M |
| June 30, 2015 | -8.554M |
| March 31, 2015 | -7.419M |
| December 31, 2014 | -6.025M |
| September 30, 2014 | -5.395M |
| June 30, 2014 | -7.093M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 10.26M |
| Alnylam Pharmaceuticals, Inc. | 271.15M |
| Anika Therapeutics, Inc. | 6.716M |
| Vericel Corp. | 15.68M |
| Biogen, Inc. | 375.40M |